MedPath

中国大冢制药有限公司

Ownership
-
Established
1981-04-21
Employees
-
Market Cap
-
Website
https://www.chinaotsuka.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

70

NMPA:70

Drug Approvals

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H20247331
Approval Date
Dec 30, 2024
NMPA

Sugammadex Sodium Injection

Product Name
舒更葡糖钠注射液
Approval Number
国药准字H20249534
Approval Date
Dec 1, 2024
NMPA

Peramivir Injection

Product Name
帕拉米韦注射液
Approval Number
国药准字H20244971
Approval Date
Sep 26, 2024
NMPA

Magnesium Sulfate Injection

Product Name
硫酸镁注射液
Approval Number
国药准字H20244278
Approval Date
Jun 28, 2024
NMPA

Palonosetron Hydrochloride Injection

Product Name
盐酸帕洛诺司琼注射液
Approval Number
国药准字H20244364
Approval Date
Jun 28, 2024
NMPA

Furosemide Injection

Product Name
呋塞米注射液
Approval Number
国药准字H20243838
Approval Date
May 28, 2024
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H20067072
Approval Date
Aug 23, 2023
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H20066692
Approval Date
Aug 23, 2023
NMPA

Lidocaine Hydrochloride Injection

Product Name
盐酸利多卡因注射液
Approval Number
国药准字H20065388
Approval Date
May 29, 2023
NMPA

Lidocaine Hydrochloride Injection

Product Name
盐酸利多卡因注射液
Approval Number
国药准字H20065387
Approval Date
May 26, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.